21.55

0.19% 0.0352

Avadel Pharmaceuticals Plc (AVDL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AVDL Giù? Forum Previsione

Precedente Chiudi:

$21.51

Aprire:

$21.53

Volume 24 ore:

746.32K

Relative Volume:

0.25

Capitalizzazione di mercato:

$2.11B

Reddito:

$221.08M

Utile/perdita netta:

$-2.92M

Rapporto P/E:

-652.88

EPS:

-0.033

Flusso di cassa netto:

$5.89M

1 W Prestazione:

+0.33%

1M Prestazione:

-0.14%

6M Prestazione:

+91.90%

1 anno Prestazione:

+169.38%

Intervallo 1D:

$21.50

$21.56

Intervallo di 1 settimana:

$21.48

$21.56

Portata 52W:

$6.38

$23.57

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Nome

Avadel Pharmaceuticals Plc

Settore

Healthcare (1120)

Industria

Drug Manufacturers - Specialty & Generic (86)

Telefono

636-449-1830

Indirizzo

10 EARLSFORT TERRACE, DUBLIN 2

Dipendente

188

Cinguettio

@AvadelPharma

Prossima data di guadagno

2025-03-03

Ultimi documenti SEC

AVDL's Discussions on Twitter

Confronta AVDL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AVDL Avadel Pharmaceuticals Plc	21.55	2.11B	221.08M	-2.92M	5.89M	-0.033
ZTS Zoetis Inc	124.02	55.12B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.96	50.80B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.27	45.60B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.64	36.04B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	470.90	20.23B	3.08B	1.24B	1.07B	25.61

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-23	Downgrade	H.C. Wainwright	Buy → Neutral
2025-09-03	Iniziato	Wells Fargo	Equal Weight
2025-07-18	Ripresa	H.C. Wainwright	Buy
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-06-12	Iniziato	Rodman & Renshaw	Buy
2024-03-05	Reiterato	H.C. Wainwright	Buy
2024-03-05	Reiterato	Needham	Buy
2024-03-05	Reiterato	Oppenheimer	Outperform
2024-02-06	Iniziato	UBS	Buy
2022-11-30	Aggiornamento	Jefferies	Hold → Buy
2022-08-10	Downgrade	Jefferies	Buy → Hold
2022-07-28	Ripresa	Craig Hallum	Buy
2022-05-26	Downgrade	Stifel	Buy → Hold
2021-09-23	Iniziato	Needham	Buy
2020-07-31	Iniziato	Oppenheimer	Outperform
2020-07-21	Iniziato	SVB Leerink	Outperform
2020-06-30	Iniziato	H.C. Wainwright	Buy
2020-04-03	Iniziato	Jefferies	Buy
2020-03-12	Iniziato	Stifel	Buy
2020-02-26	Iniziato	Piper Sandler	Overweight
2020-01-30	Iniziato	Craig Hallum	Buy
2019-06-14	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-02-08	Downgrade	Ladenburg Thalmann	Buy → Neutral

Mostra tutto

Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie

Jan 21, 2026

Avadel Pharmaceuticals Announces Court Hearing for Acquisition - TradingView — Track All Markets

Jan 20, 2026

Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan

Jan 20, 2026

Jan 19, 2026

State Street Increases Stake in Avadel Pharmaceuticals by 2.39% - Intellectia AI

Jan 19, 2026

Jan 17, 2026

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria

Jan 17, 2026

Bank of America discloses 1.3% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Bank of America discloses 2.39% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 17, 2026

Jan 16, 2026

TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

BlackRock discloses 6.94% stake in Avadel Pharmaceuticals - Investing.com

Jan 16, 2026

Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com

Jan 16, 2026

Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa

Jan 16, 2026

Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals - Investing.com India

Jan 16, 2026

Bank of America discloses 1.3% stake in Avadel Pharmaceuticals - Investing.com India

Jan 16, 2026

Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com India

Jan 16, 2026

UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

BlackRock discloses 6.92% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

Bank of America discloses 1.32% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria

Jan 16, 2026

Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria

Jan 16, 2026

Morgan Stanley Capital Services discloses Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria

Jan 16, 2026

Jan 15, 2026

Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals

Jan 15, 2026

Sentiment Review: Can Annovis Bio Inc disrupt its industryBond Market & Weekly Setup with High ROI Potential - baoquankhu1.vn

Jan 15, 2026

UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals - Investing.com India

Jan 15, 2026

BlackRock discloses 6.92% stake in Avadel Pharmaceuticals - Investing.com

Jan 15, 2026